CYTOMEL Tablet Ref.[10799] Active ingredients: Liothyronine

Source: FDA, National Drug Code (US)  Revision Year: 2019 

Product description

CYTOMEL tablets contain the active ingredient, liothyronine (L-triiodothyronine or LT3), a synthetic form of a thyroid hormone liothyronine in sodium salt form. It is chemically designated as L-Tyrosine, O-(4-hydroxy-3-iodophenyl)-3,5-diiodo-, monosodium salt. The molecular formula, molecular weight and structural formula of liothyronine sodium are given below.

CYTOMEL tablets contain liothyronine sodium equivalent to liothyronine in 5 mcg, 25 mcg, and 50 mcg. Inactive ingredients consist of calcium sulfate, corn starch, gelatin, stearic acid, sucrose and talc.

Dosage Forms and Strengths

Tablets (round, white to off-white) available as follows:

  • 5 mcg: debossed with KPI on one side and 115 on the other side
  • 25 mcg: scored on one side and debossed with KPI and 116 on the other side
  • 50 mcg: scored on one side and debossed with KPI and 117 on the other side
How Supplied

CYTOMEL tablets (round, white to off-white) are supplied as follows:

Strength Tablet Markings NDC – bottles of 100
5 mcg Debossed with KPI on one side and 115 on the other side60793-115-01
25 mcg Scored on one side and debossed with KPI and 116 on the other side60793-116-01
50 mcg Scored on one side and debossed with KPI and 117 on the other side60793-117-01

Drugs

Drug Countries
CYTOMEL Canada, Malta, Netherlands, United States
 
Next: Usage >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈